405 nm诱导的自发荧光可区分良性与原发潜在进展性肝结节
前瞻性离体研究纳入40例切除肝标本共53个原发结节,用25G光纤针行组织内光谱测量,比较结节与邻近肝实质635和670 nm自发荧光峰导数。良性结节两峰Δ导数均显著高于潜在进展性结节(P<0.0001),鉴别敏感度78%、特异度91%。提示自发荧光成像有望优化超声靶向肝活检。
要点
- 405 nm自发荧光光谱可区分良性结节与潜在进展性原发肝结节。
- 635和670 nm峰Δ导数在良性结节中显著更高,敏感度78%、特异度91%。
- 该技术为离体研究,尚未常规用于在体靶向活检。
核心结论
- 405 nm诱导的自发荧光能区分良性原发肝结节与潜在进展性结节,有望优化超声靶向肝活检。
研究设计与样本
- IRB批准的前瞻性离体研究,纳入40例切除肝标本共53个原发肝结节。
- 用25G光纤针行组织内光谱测量,结节与邻近肝实质各测5次自发荧光。
- 比较635和670 nm自发荧光峰的光谱导数,采用Kruskal-Wallis及Mann-Whitney检验。
关键影像表现/征象
- 结节与邻近肝实质的405 nm诱导自发荧光存在可区分的差异。
- 良性结节635 nm Δ导数为32.9±4.5,潜在进展性结节为15.3±1.4(p<0.0001)。
- 良性结节670 nm Δ导数为5.7±0.6,潜在进展性结节为2.5±0.1(p<0.0001)。
诊断标准与关键数值
- 以635和670 nm自发荧光峰Δ导数鉴别良性结节与潜在进展性结节,敏感度78%、特异度91%。
- 潜在进展性结节包括34个肝细胞癌、4个肝内胆管癌、4个肝细胞腺瘤。
- 良性结节包括5个局灶性结节增生、6个再生结节。
临床应用与阅片要点
- 阅片和报告目前仍以常规影像为主,该自发荧光参数属离体研究阶段。
- 未来或可将自发荧光成像嵌入活检针,在超声引导基础上优化肝结节靶向取样。
局限性
- 研究为离体切除标本,非在体测量,结论外推至临床在体应用需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the performance of 405 nm-induced autofluorescence for the characterization of primary liver nodules on ex vivo resected specimens.
MATERIALS AND METHODS: Forty resected liver specimens bearing 53 primary liver nodules were included in this IRB-approved prospective study. Intratissular spectroscopic measurements were performed using a 25-G fibered-needle on all ex vivo specimens: 5 autofluorescence measurements were performed in both nodules and adjacent parenchyma. The spectra derivatives of the 635 and 670 nm autofluorescence peaks observed in nodules and in adjacent liver parenchyma were compared (Kruskal-Wallis and Mann-Whitney when appropriate).
RESULTS: A total of 42 potentially evolutive primary liver nodules-34 hepatocellular carcinomas, 4 intrahepatic cholangiocarcinomas, 4 hepatocellular adenomas-and 11 benign nodules-5 focal nodular hyperplasias, 6 regenerative nodules-were included. Both 635 and 670 nm Δderivatives were significantly higher in benign as compared to potentially evolutive (PEV) nodules (respectively 32.9 ± 4.5 vs 15.3 ± 1.4; p < 0.0001 and 5.7 ± 0.6 vs 2.5 ± 0.1; p < 0.0001) with respective sensitivity and specificity of 78% and 91% for distinguishing PEV from benign nodules.
CONCLUSION: 405 nm-induced autofluorescence enables the discrimination of benign from PEV primary liver nodules, suggesting that autofluorescence imaging could be used to optimize US targeted liver biopsies.
KEY POINTS: • 405 nm-induced autofluorescence can distinguish liver tumors from the adjacent liver parenchyma. • The analysis of autofluorescence imaging observed within primary liver tumors can discriminate benign tumors from those requiring follow-up or targeted liver biopsy. • In current practice, autofluorescence imaging could be embedded within biopsy needle, to enable, in addition to ultrasound guidance, optimal targeting of liver nodules which could optimize tissue sampling.
引用
- Benoit C, Rodrigues A, Calderaro J, et al. Autofluorescence imaging within the liver: a promising tool for the detection and characterization of primary liver tumors. Eur Radiol. 2021. PMID: 34694452. doi:10.1007/s00330-021-08307-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。